These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 26849944)

  • 1. Up-regulation of Nrf2 is involved in FGF21-mediated fenofibrate protection against type 1 diabetic nephropathy.
    Cheng Y; Zhang J; Guo W; Li F; Sun W; Chen J; Zhang C; Lu X; Tan Y; Feng W; Fu Y; Liu GC; Xu Z; Cai L
    Free Radic Biol Med; 2016 Apr; 93():94-109. PubMed ID: 26849944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Akt2 in the Protective Effect of Fenofibrate against Diabetic Nephropathy.
    Cheng Y; Zhang X; Ma F; Sun W; Wang W; Yu J; Shi Y; Cai L; Xu Z
    Int J Biol Sci; 2020; 16(4):553-567. PubMed ID: 32025205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fenofibrate increases cardiac autophagy via FGF21/SIRT1 and prevents fibrosis and inflammation in the hearts of Type 1 diabetic mice.
    Zhang J; Cheng Y; Gu J; Wang S; Zhou S; Wang Y; Tan Y; Feng W; Fu Y; Mellen N; Cheng R; Ma J; Zhang C; Li Z; Cai L
    Clin Sci (Lond); 2016 Apr; 130(8):625-41. PubMed ID: 26795437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibroblast growth factor-21 prevents diabetic cardiomyopathy via AMPK-mediated antioxidation and lipid-lowering effects in the heart.
    Yang H; Feng A; Lin S; Yu L; Lin X; Yan X; Lu X; Zhang C
    Cell Death Dis; 2018 Feb; 9(2):227. PubMed ID: 29445083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblast Growth Factor 21 Attenuates Diabetes-Induced Renal Fibrosis by Negatively Regulating TGF-β-p53-Smad2/3-Mediated Epithelial-to-Mesenchymal Transition via Activation of AKT.
    Lin S; Yu L; Ni Y; He L; Weng X; Lu X; Zhang C
    Diabetes Metab J; 2020 Feb; 44(1):158-172. PubMed ID: 31701691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Huangkui capsule, an extract from Abelmoschus manihot (L.) medic, improves diabetic nephropathy via activating peroxisome proliferator-activated receptor (PPAR)-α/γ and attenuating endoplasmic reticulum stress in rats.
    Ge J; Miao JJ; Sun XY; Yu JY
    J Ethnopharmacol; 2016 Aug; 189():238-49. PubMed ID: 27224243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulforaphane prevents type 2 diabetes-induced nephropathy via AMPK-mediated activation of lipid metabolic pathways and Nrf2 antioxidative function.
    Li Z; Guo H; Li J; Ma T; Zhou S; Zhang Z; Miao L; Cai L
    Clin Sci (Lond); 2020 Sep; 134(18):2469-2487. PubMed ID: 32940670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigallocatechin gallate upregulates NRF2 to prevent diabetic nephropathy via disabling KEAP1.
    Sun W; Liu X; Zhang H; Song Y; Li T; Liu X; Liu Y; Guo L; Wang F; Yang T; Guo W; Wu J; Jin H; Wu H
    Free Radic Biol Med; 2017 Jul; 108():840-857. PubMed ID: 28457936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sodium butyrate activates NRF2 to ameliorate diabetic nephropathy possibly via inhibition of HDAC.
    Dong W; Jia Y; Liu X; Zhang H; Li T; Huang W; Chen X; Wang F; Sun W; Wu H
    J Endocrinol; 2017 Jan; 232(1):71-83. PubMed ID: 27799462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fenofibrate improves renal function by amelioration of NOX-4, IL-18, and p53 expression in an experimental model of diabetic nephropathy.
    Yaribeygi H; Mohammadi MT; Rezaee R; Sahebkar A
    J Cell Biochem; 2018 Sep; 119(9):7458-7469. PubMed ID: 29761900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic potential of digitoflavone on diabetic nephropathy: nuclear factor erythroid 2-related factor 2-dependent anti-oxidant and anti-inflammatory effect.
    Yang Y; Chen G; Cheng X; Teng Z; Cai X; Yang J; Sun X; Lu W; Wang X; Yao Y; Hu C; Cao P
    Sci Rep; 2015 Jul; 5():12377. PubMed ID: 26205695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel compound AB38b attenuates oxidative stress and ECM protein accumulation in kidneys of diabetic mice through modulation of Keap1/Nrf2 signaling.
    Du L; Wang L; Wang B; Wang J; Hao M; Chen YB; Li XZ; Li Y; Jiang YF; Li CC; Yang H; Gu XK; Yin XX; Lu Q
    Acta Pharmacol Sin; 2020 Mar; 41(3):358-372. PubMed ID: 31645661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential role for Nrf2 activation in the therapeutic effect of MG132 on diabetic nephropathy in OVE26 diabetic mice.
    Cui W; Li B; Bai Y; Miao X; Chen Q; Sun W; Tan Y; Luo P; Zhang C; Zheng S; Epstein PN; Miao L; Cai L
    Am J Physiol Endocrinol Metab; 2013 Jan; 304(1):E87-99. PubMed ID: 23132297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of ferroptosis by up-regulating Nrf2 delayed the progression of diabetic nephropathy.
    Li S; Zheng L; Zhang J; Liu X; Wu Z
    Free Radic Biol Med; 2021 Jan; 162():435-449. PubMed ID: 33152439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sulforaphane prevents angiotensin II-induced cardiomyopathy by activation of Nrf2 via stimulating the Akt/GSK-3ß/Fyn pathway.
    Xin Y; Bai Y; Jiang X; Zhou S; Wang Y; Wintergerst KA; Cui T; Ji H; Tan Y; Cai L
    Redox Biol; 2018 May; 15():405-417. PubMed ID: 29353218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fenofibrate ameliorates diabetic retinopathy by modulating Nrf2 signaling and NLRP3 inflammasome activation.
    Liu Q; Zhang F; Zhang X; Cheng R; Ma JX; Yi J; Li J
    Mol Cell Biochem; 2018 Aug; 445(1-2):105-115. PubMed ID: 29264825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metallothionein plays a prominent role in the prevention of diabetic nephropathy by sulforaphane via up-regulation of Nrf2.
    Wu H; Kong L; Cheng Y; Zhang Z; Wang Y; Luo M; Tan Y; Chen X; Miao L; Cai L
    Free Radic Biol Med; 2015 Dec; 89():431-42. PubMed ID: 26415026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection by sulforaphane from type 1 diabetes-induced testicular apoptosis is associated with the up-regulation of Nrf2 expression and function.
    Jiang X; Bai Y; Zhang Z; Xin Y; Cai L
    Toxicol Appl Pharmacol; 2014 Sep; 279(2):198-210. PubMed ID: 24967692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SP600125 suppresses
    Zhang H; Liu X; Zhou S; Jia Y; Li Y; Song Y; Wang J; Wu H
    J Mol Endocrinol; 2018 Feb; 60(2):145-157. PubMed ID: 29273684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Moringa oleifera Lam. seed extract protects kidney function in rats with diabetic nephropathy by increasing GSK-3β activity and activating the Nrf2/HO-1 pathway.
    Wen Y; Liu Y; Huang Q; Liu R; Liu J; Zhang F; Liu S; Jiang Y
    Phytomedicine; 2022 Jan; 95():153856. PubMed ID: 34856477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.